First Eagle Investment Management
IRWD icon

First Eagle Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

First Eagle Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,104,225
Closed -$7.2M – 408
2024
Q2 		$7.2M Buy
1,104,225
+102,000
+10% +$721K 0.02% 217
2024
Q1 		$8.73M Buy
1,002,225
+95,000
+10% +$1.15M 0.02% 187
2023
Q4 		$10.4M Buy
907,225
+90,636
+11% +$897K 0.02% 137
2023
Q3 		$7.86M Buy
816,589
+226,700
+38% +$2.22M 0.02% 146
2023
Q2 		$6.28M Buy
589,889
+98,525
+20% +$1.06M 0.02% 169
2023
Q1 		$5.17M Buy
491,364
+150,834
+44% +$1.69M 0.01% 161
2022
Q4 		$4.22M Buy
340,530
+85,030
+33% +$965K 0.01% 148
2022
Q3 		$2.65M Buy
+255,500
New +$2.9M 0.01% 173

Other funds holding IRWD

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return